Weighted Average Number of Shares Outstanding, Basic of ENZO BIOCHEM INC from 31 Dec 2010 to 30 Apr 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
ENZO BIOCHEM INC quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Dec 2010 to 30 Apr 2025.
  • ENZO BIOCHEM INC Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Apr 2025 was 52,403, a 2.3% increase year-over-year.
  • ENZO BIOCHEM INC annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 50,902, a 3.5% increase from 2023.
  • ENZO BIOCHEM INC annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 49,160, a 1.2% increase from 2022.
  • ENZO BIOCHEM INC annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 48,594, a 0.84% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

ENZO BIOCHEM INC Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 52,403 +1,189 +2.3% 01 Feb 2025 30 Apr 2025 10-Q 16 Jun 2025 2025 Q3
Q4 2024 52,297 +1,807 +3.6% 01 Nov 2024 31 Jan 2025 10-Q 17 Mar 2025 2025 Q2
Q3 2024 52,244 +2,060 +4.1% 01 Aug 2024 31 Oct 2024 10-Q 16 Dec 2024 2025 Q1
Q2 2024 50,902 +1,742 +3.5% 01 May 2024 31 Jul 2024 10-K 29 Oct 2024 2024 FY
Q1 2024 51,214 +1,830 +3.7% 01 Feb 2024 30 Apr 2024 10-Q 16 Jun 2025 2025 Q3
Q4 2023 50,490 +1,761 +3.6% 01 Nov 2023 31 Jan 2024 10-Q 17 Mar 2025 2025 Q2
Q3 2023 50,184 +1,464 +3% 01 Aug 2023 31 Oct 2023 10-Q 16 Dec 2024 2025 Q1
Q2 2023 49,160 +566 +1.2% 01 May 2023 31 Jul 2023 10-K 29 Oct 2024 2024 FY
Q1 2023 49,384 +671 +1.4% 01 Feb 2023 30 Apr 2023 10-Q 13 Jun 2024 2024 Q3
Q4 2022 48,729 +257 +0.53% 01 Nov 2022 31 Jan 2023 10-Q 13 Mar 2024 2024 Q2
Q3 2022 48,720 +248 +0.51% 01 Aug 2022 31 Oct 2022 10-Q 15 Dec 2023 2024 Q1
Q2 2022 48,594 +403 +0.84% 01 May 2022 31 Jul 2022 10-K 03 Nov 2023 2023 FY
Q1 2022 48,713 +322 +0.66% 01 Feb 2022 30 Apr 2022 10-Q 14 Jun 2023 2023 Q3
Q4 2021 48,472 +466 +0.97% 01 Nov 2021 31 Jan 2022 10-Q 20 Mar 2023 2023 Q2
Q3 2021 48,472 +577 +1.2% 01 Aug 2021 31 Oct 2021 10-Q 12 Dec 2022 2023 Q1
Q2 2021 48,191 +495 +1% 01 May 2021 31 Jul 2021 10-K 14 Oct 2022 2022 FY
Q1 2021 48,391 +611 +1.3% 01 Feb 2021 30 Apr 2021 10-Q 09 Jun 2022 2022 Q3
Q4 2020 48,006 +449 +0.94% 01 Nov 2020 31 Jan 2021 10-Q 14 Mar 2022 2022 Q2
Q3 2020 47,895 +338 +0.71% 01 Aug 2020 31 Oct 2020 10-Q 15 Dec 2021 2022 Q1
Q2 2020 47,696 01 May 2020 31 Jul 2020 10-K 14 Oct 2022 2022 FY
Q1 2020 47,780 +328 +0.69% 01 Feb 2020 30 Apr 2020 10-Q 11 Jun 2021 2021 Q3
Q4 2019 47,557 01 Nov 2019 31 Jan 2020 10-Q 16 Mar 2021 2021 Q2
Q3 2019 47,557 01 Aug 2019 31 Oct 2019 10-Q 11 Dec 2020 2021 Q1
Q1 2019 47,452 +379 +0.8% 01 Feb 2019 30 Apr 2019 10-Q 09 Jun 2020 2020 Q3
Q1 2018 47,073 +706 +1.5% 01 Feb 2018 30 Apr 2018 10-Q 10 Jun 2019 2019 Q3
Q3 2017 46,914 +642 +1.4% 01 Aug 2017 31 Oct 2017 10-Q 07 Dec 2017 2018 Q1
Q2 2017 46,350 +197 +0.43% 01 May 2017 31 Jul 2017 10-K 15 Oct 2019 2019 FY
Q1 2017 46,367 +166 +0.36% 01 Feb 2017 30 Apr 2017 10-Q 08 Jun 2017 2017 Q3
Q4 2016 46,292 +215 +0.47% 01 Nov 2016 31 Jan 2017 10-Q 13 Mar 2017 2017 Q2
Q3 2016 46,272 +204 +0.44% 01 Aug 2016 31 Oct 2016 10-Q 07 Dec 2017 2018 Q1
Q2 2016 46,153 +798 +1.8% 01 May 2016 31 Jul 2016 10-K 15 Oct 2018 2018 FY
Q1 2016 46,201 +404 +0.88% 01 Feb 2016 30 Apr 2016 10-Q 08 Jun 2017 2017 Q3
Q4 2015 46,077 +1,077 +2.4% 01 Nov 2015 31 Jan 2016 10-Q 13 Mar 2017 2017 Q2
Q3 2015 46,068 +1,504 +3.4% 01 Aug 2015 31 Oct 2015 10-Q 08 Dec 2016 2017 Q1
Q2 2015 45,355 01 May 2015 31 Jul 2015 10-K 27 Sep 2017 2017 FY
Q1 2015 45,797 01 Feb 2015 30 Apr 2015 10-Q 08 Jun 2016 2016 Q3
Q4 2014 45,000 01 Nov 2014 31 Jan 2015 10-Q 09 Mar 2016 2016 Q2
Q3 2014 44,564 01 Aug 2014 31 Oct 2014 10-Q 08 Dec 2015 2015 Q1

ENZO BIOCHEM INC Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 50,902 +1,742 +3.5% 01 Aug 2023 31 Jul 2024 10-K 29 Oct 2024 2024 FY
2023 49,160 +566 +1.2% 01 Aug 2022 31 Jul 2023 10-K 29 Oct 2024 2024 FY
2022 48,594 +403 +0.84% 01 Aug 2021 31 Jul 2022 10-K 03 Nov 2023 2023 FY
2021 48,191 +495 +1% 01 Aug 2020 31 Jul 2021 10-K 14 Oct 2022 2022 FY
2020 47,696 +345 +0.73% 01 Aug 2019 31 Jul 2020 10-K 14 Oct 2022 2022 FY
2019 47,351 +379 +0.81% 01 Aug 2018 31 Jul 2019 10-K 12 Oct 2021 2021 FY
2018 46,972 +622 +1.3% 01 Aug 2017 31 Jul 2018 10-K 19 Oct 2020 2020 FY
2017 46,350 +197 +0.43% 01 Aug 2016 31 Jul 2017 10-K 15 Oct 2019 2019 FY
2016 46,153 +798 +1.8% 01 Aug 2015 31 Jul 2016 10-K 15 Oct 2018 2018 FY
2015 45,355 +2,794 +6.6% 01 Aug 2014 31 Jul 2015 10-K 27 Sep 2017 2017 FY
2014 42,561 -39,564,439 01 Aug 2013 31 Jul 2014 10-K 13 Oct 2016 2016 FY
2013 39,607,000* +39,568,202 01 Aug 2012 31 Jul 2013 10-K 13 Oct 2015 2015 FY
2012 38,798 +441 +1.2% 01 Jan 2012 31 Dec 2012 10-K 15 Oct 2012 2012 FY
2011 38,357 +356 +0.94% 01 Jan 2011 31 Dec 2011 10-K 15 Oct 2012 2012 FY
2010 38,001 01 Jan 2010 31 Dec 2010 10-K 15 Oct 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.